Tryton Medical, Inc. Broadcasts Successful Live Case Using Company’s Side-Branch Stent(TM) to Definitively Treat Bifurcation Lesions in Front of 1,000 Cardiologists at JIM 2007 Conference in Rome

NEWTON, Mass.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that it transmitted a live satellite feed of a clinical case, which was performed at the Helios Heart Center in Siegburg Germany, to an audience of over 1,000 interventional cardiologists at the Joint Interventional Meeting (JIM 2007) in Rome. The procedure was performed by Charles A. Simonton, III, M.D., FACC, FSCAI, Director of Adult Cardiology Research at Carolinas Heart Institute, in Charlotte, NC. “The Tryton Side-Branch Stent allowed us to treat a difficult bifurcation lesion with a superb angiographic result, through a 6-French guide, without interfering with my selection of a stent for the main vessel. The final appearance of the side branch origin was particularly impressive, I am not sure we could obtain such a result without Tryton,” said Dr. Simonton.

MORE ON THIS TOPIC